Dispute on eye drop size fails to catch Supreme Court's eye

A dispute about the size of eye drops has failed to catch the eye of the Supreme Court.

Drug companies including Allergan, Bausch & Lomb, Merck and Pfizer had asked the court to get involved in the case. The companies were sued by patients using their to treat glaucoma and other eye conditions. The high court said Monday that it won't take the case. That means a lower-court decision allowing the lawsuit to go forward will stand.

The patients said that ' bottles dispense drops that are too large, leaving wasted medication running down their faces. The patients said they would pay less for their treatment if their bottles were designed to dispense smaller drops.

Companies said the patients shouldn't be able to sue in federal court.


Explore further

Court: Yes, there is doctor-patient confidentiality

© 2018 The Associated Press. All rights reserved.

Citation: Dispute on eye drop size fails to catch Supreme Court's eye (2018, May 21) retrieved 16 November 2019 from https://medicalxpress.com/news/2018-05-dispute-eye-size-supreme-court.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments